{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:07:07Z","timestamp":1793041627515,"version":"4.5.0"},"reference-count":251,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:00:00Z","timestamp":1754438400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Research Foundation of Korea Grants","award":["NRF-2020R1A6A1A03042854"],"award-info":[{"award-number":["NRF-2020R1A6A1A03042854"]}]},{"name":"National Research Foundation of Korea Grants","award":["NRF-2023M3A9J4057780"],"award-info":[{"award-number":["NRF-2023M3A9J4057780"]}]},{"name":"National Research Foundation of Korea Grants","award":["NRF-2019R1F1A1060071"],"award-info":[{"award-number":["NRF-2019R1F1A1060071"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Skeletal muscle atrophy is a critical health issue affecting the quality of life of elderly individuals and patients with chronic diseases. These conditions induce dysregulation of glucocorticoid (GC) secretion. GCs play a critical role in maintaining homeostasis in the stress response and glucose metabolism. However, prolonged exposure to GC is directly linked to muscle atrophy, which is characterized by a reduction in muscle size and weight, particularly affecting fast-twitch muscle fibers. The GC-activated glucocorticoid receptor (GR) decreases protein synthesis and facilitates protein breakdown. Numerous antagonists have been developed to mitigate GC-induced muscle atrophy, including 11\u03b2-HSD1 inhibitors and myostatin and activin receptor blockers. However, the clinical trial results have fallen short of the expected efficacy. Recently, several emerging pathways and targets have been identified. For instance, GC-induced sirtuin 6 isoform (SIRT6) expression suppresses AKT\/mTORC1 signaling. Lysine-specific demethylase 1 (LSD1) cooperates with the GR for the transcription of atrogenes. The kynurenine pathway and indoleamine 2,3-dioxygenase 1 (IDO-1) also play crucial roles in protein synthesis and energy production in skeletal muscle. Therefore, a deeper understanding of the complexities of GR transactivation and transrepression will provide new strategies for the discovery of novel drugs to overcome the detrimental effects of GCs on muscle tissues.<\/jats:p>","DOI":"10.3390\/ijms26157616","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T15:09:53Z","timestamp":1754492993000},"page":"7616","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Glucocorticoid-Mediated Skeletal Muscle Atrophy: Molecular Mechanisms and Potential Therapeutic Targets"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-6139-3773","authenticated-orcid":false,"given":"Uttapol","family":"Permpoon","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Institute of Pharmaceutical Science and Technology, Hanyang University ERICA, Ansan 15588, Gyeonggi-do, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiyeong","family":"Moon","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Institute of Pharmaceutical Science and Technology, Hanyang University ERICA, Ansan 15588, Gyeonggi-do, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6988-1059","authenticated-orcid":false,"given":"Chul Young","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Institute of Pharmaceutical Science and Technology, Hanyang University ERICA, Ansan 15588, Gyeonggi-do, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5292-9335","authenticated-orcid":false,"given":"Tae-gyu","family":"Nam","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Institute of Pharmaceutical Science and Technology, Hanyang University ERICA, Ansan 15588, Gyeonggi-do, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"105807","DOI":"10.1016\/j.phrs.2021.105807","article-title":"Skeletal muscle atrophy: From mechanisms to treatments","volume":"172","author":"Yin","year":"2021","journal-title":"Pharmacol. Res."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"16","DOI":"10.5187\/jast.2022.e114","article-title":"The roles of growth factors and hormones in the regulation of muscle satellite cells for cultured meat production","volume":"65","author":"Ahmad","year":"2023","journal-title":"J. Anim. Sci. Technol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Yoshida, T., and Delafontaine, P. (2020). Mechanisms of IGF-1-Mediated Regulation of Skeletal Muscle Hypertrophy and Atrophy. Cells, 9.","DOI":"10.3390\/cells9091970"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Lee, J.H., and Jun, H.S. (2019). Role of myokines in regulating skeletal muscle mass and function. Front. Physiol., 10.","DOI":"10.3389\/fphys.2019.00042"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Zhang, H., Qi, G., Wang, K., Yang, J., Shen, Y., Yang, X., Chen, X., Yao, X., Gu, X., and Qi, L. (2023). Oxidative stress: Roles in skeletal muscle atrophy. Biochem. Pharmacol., 214.","DOI":"10.1016\/j.bcp.2023.115664"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"afac220","DOI":"10.1093\/ageing\/afac220","article-title":"Sarcopenia definition, diagnosis and treatment: Consensus is growing","volume":"51","author":"Sayer","year":"2022","journal-title":"Age Ageing"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"El Assar, M., \u00c1lvarez-Bustos, A., Sosa, P., Angulo, J., and Rodr\u00edguez-Ma\u00f1as, L. (2022). Effect of Physical Activity\/Exercise on Oxidative Stress and Inflammation in Muscle and Vascular Aging. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23158713"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"191","DOI":"10.37349\/eemd.2024.00016","article-title":"Endogenous glucocorticoids during skeletal ageing","volume":"1","author":"Macfarlane","year":"2024","journal-title":"Explor. Endocr. Metab. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"564","DOI":"10.3803\/EnM.2021.1069","article-title":"Cushing Syndrome Associated Myopathy: It Is Time for a Change","volume":"36","author":"Reincke","year":"2021","journal-title":"Endocrinol. Metab."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Braun, T.P., and Marks, D.L. (2015). The regulation of muscle mass by endogenous glucocorticoids. Front. Physiol., 6.","DOI":"10.3389\/fphys.2015.00012"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.2337\/db09-0525","article-title":"11\u03b2-hydroxysteroid dehydrogenase type 1 regulates glucocorticoid- induced insulin resistance in skeletal muscle","volume":"58","author":"Morgan","year":"2009","journal-title":"Diabetes"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.cmet.2011.01.001","article-title":"Crosstalk between glucocorticoid receptor and nutritional sensor mTOR in skeletal muscle","volume":"13","author":"Shimizu","year":"2011","journal-title":"Cell Metab."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.rvsc.2012.07.018","article-title":"Dexamethasone-induced skeletal muscle atrophy was associated with upregulation of myostatin promoter activity","volume":"94","author":"Qin","year":"2013","journal-title":"Res. Vet. Sci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1096\/fj.09-151480","article-title":"FOXO3a mediates signaling crosstalk that coordinates ubiquitin and atrogin-1\/MAFbx expression during glucocorticoid-induced skeletal muscle atrophy","volume":"24","author":"Zheng","year":"2010","journal-title":"FASEB J."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.steroids.2005.09.019","article-title":"Rapid inhibitory effect of glucocorticoids on airway smooth muscle contractions in guinea pigs","volume":"71","author":"Sun","year":"2006","journal-title":"Steroids"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1042\/bj3210707","article-title":"Effects of Glucocorticoid Excess on the Sensitivity of Glucose Transport and Metabolism to Insulin in Rat Skeletal Muscle","volume":"321","author":"Dimitriadis","year":"1997","journal-title":"Biochem. J."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"5415","DOI":"10.1038\/s41467-022-32905-w","article-title":"Sirtuin 6 inhibition protects against glucocorticoid-induced skeletal muscle atrophy by regulating IGF\/PI3K\/AKT signaling","volume":"13","author":"Mishra","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1038\/s41467-024-47846-9","article-title":"LSD1 inhibition circumvents glucocorticoid-induced muscle wasting of male mice","volume":"15","author":"Cai","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_19","first-page":"1","article-title":"The effects of kynurenine metabolites on skeletal muscle in vivo and in vitro","volume":"34","author":"Kaiser","year":"2020","journal-title":"FASEB J."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Ankrum, J.A., Dastidar, R.G., Ong, J.F., Levy, O., and Karp, J.M. (2014). Performance-enhanced mesenchymal stem cells via intracellular delivery of steroids. Sci. Rep., 4.","DOI":"10.1038\/srep04645"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1080\/10253890.2018.1470238","article-title":"Role of glucocorticoid negative feedback in the regulation of HPA axis pulsatility","volume":"21","author":"Gjerstad","year":"2018","journal-title":"Stress"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"383","DOI":"10.31887\/DCNS.2006.8.4\/ssmith","article-title":"The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stress","volume":"8","author":"Smith","year":"2006","journal-title":"Dialogues. Clin. Neurosci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s13679-012-0028-5","article-title":"The Hypothalamic-Pituitary-Adrenal Axis, Obesity, and Chronic Stress Exposure: Sleep and the HPA Axis in Obesity","volume":"1","author":"Lucassen","year":"2012","journal-title":"Curr. Obes. Rep."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Akalestou, E., Genser, L., and Rutter, G.A. (2020). Glucocorticoid Metabolism in Obesity and Following Weight Loss. Front. Endocrinol., 11.","DOI":"10.3389\/fendo.2020.00059"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1161\/01.HYP.31.3.885","article-title":"Gene Expression of 11\u03b2-Hydroxysteroid Dehydrogenase Type 1 and Type 2 in the Kidneys of Insulin-Dependent Diabetic Rats","volume":"31","author":"Liu","year":"1998","journal-title":"Hypertension"},{"key":"ref_26","first-page":"784520","article-title":"A Review of Hypothalamic-Pituitary-Adrenal Axis Function in Chronic Fatigue Syndrome","volume":"2013","author":"Tomas","year":"2013","journal-title":"Int. Sch. Res. Not."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Demorrow, S. (2018). Role of the hypothalamic\u2013pituitary\u2013adrenal axis in health and disease. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19040986"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1210\/endrev\/bnae008","article-title":"The Glucocorticoid Receptor: Isoforms, Functions, and Contribution to Glucocorticoid Sensitivity","volume":"45","author":"Lockett","year":"2024","journal-title":"Endocr. Rev."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41423-020-00526-2","article-title":"New insights into the cell- and tissue-specificity of glucocorticoid actions","volume":"18","author":"Quatrini","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1210\/me.2008-0283","article-title":"Minireview: Latest Perspectives on Antiinflammatory Actions of Glucocorticoids","volume":"23","author":"Haegeman","year":"2009","journal-title":"Mol. Endocrinol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1084\/jem.20180595","article-title":"Immune regulation by glucocorticoids can be linked to cell type\u2013dependent transcriptional responses","volume":"216","author":"Franco","year":"2019","journal-title":"J. Exp. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/embo-reports\/kvf119","article-title":"A role for endogenous glucocorticoids in wound repair","volume":"3","author":"Grose","year":"2002","journal-title":"EMBO Rep."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Gerber, A.N., Newton, R., and Sasse, S.K. (2021). Repression of transcription by the glucocorticoid receptor: A parsimonious model for the genomics era. J. Biol. Chem., 296.","DOI":"10.1016\/j.jbc.2021.100687"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1038\/s41467-018-03780-1","article-title":"Cryptic glucocorticoid receptor-binding sites pervade genomic NF-\u03baB response elements","volume":"9","author":"Hudson","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.semarthrit.2020.09.016","article-title":"The Story Behind the Use of Glucocorticoids in the Treatment of Rheumatoid Arthritis","volume":"51","author":"Conn","year":"2021","journal-title":"Semin. Arthritis. Rheum."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Reichardt, S.D., Amouret, A., Muzzi, C., Vettorazzi, S., Tuckermann, J.P., L\u00fchder, F., and Reichardt, H.M. (2021). The role of glucocorticoids in inflammatory diseases. Cells, 10.","DOI":"10.3390\/cells10112921"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Porta, S., Danza, A., Arias, S.M., Carlomagno, A., Goizueta, M.C., Vivero, F., and Ruiz-Irastorza, G. (2020). Glucocorticoids in Systemic Lupus Erythematosus. Ten Questions and Some Issues. J. Clin. Med., 9.","DOI":"10.3390\/jcm9092709"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.abd.2023.05.005","article-title":"Side effects of chronic systemic glucocorticoid therapy: What dermatologists should know","volume":"99","author":"Tavares","year":"2024","journal-title":"An. Bras. Dermatol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1093\/rheumatology\/keaa289","article-title":"Long-term systemic glucocorticoid therapy and weight gain: A population-based cohort study","volume":"60","author":"Fardet","year":"2021","journal-title":"Rheumatology"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Beaupere, C., Liboz, A., F\u00e8ve, B., Blondeau, B., and Guillemain, G. (2021). Molecular Mechanisms of Glucocorticoid-Induced Insulin Resistance. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22020623"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jaad.2016.02.1241","article-title":"Prevention and management of glucocorticoid-induced side effects: A comprehensive review: Ocular, cardiovascular, muscular, and psychiatric side effects and issues unique to pediatric patients","volume":"76","author":"Caplan","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"E2482","DOI":"10.1073\/pnas.1323681111","article-title":"11\u03b2-HSD1 is the major regulator of the tissue-specific effects of circulating glucocorticoid excess","volume":"111","author":"Morgan","year":"2014","journal-title":"Proc. Nat. Acad. Sci. USA"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1210\/jc.2015-1516","article-title":"Gender-Specific Differences in Skeletal Muscle 11\u03b2-HSD1 Expression Across Healthy Aging","volume":"100","author":"Morgan","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/path.4806","article-title":"11\u03b2-Hydroxysteroid dehydrogenase type 1 within muscle protects against the adverse effects of local inflammation","volume":"240","author":"Hardy","year":"2016","journal-title":"J. Pathol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e181","DOI":"10.2196\/resprot.7806","article-title":"Assessing the Efficacy and Safety of an 11\u03b2-Hydroxysteroid Dehydrogenase Type 1 Inhibitor (AZD4017) in the Idiopathic Intracranial Hypertension Drug Trial, IIH:DT: Clinical Methods and Design for a Phase II Randomized Controlled Trial","volume":"6","author":"Markey","year":"2017","journal-title":"JMIR Res. Protoc."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1002\/jcph.2438","article-title":"Characterizing the Nonlinear Pharmacokinetics and Pharmacodynamics of BI 187004, an 11\u03b2-Hydroxysteroid Dehydrogenase Type 1 Inhibitor, in Humans by a Target-Mediated Drug Disposition Model","volume":"64","author":"Yuan","year":"2024","journal-title":"J. Clin. Pharmacol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1210\/clinem\/dgaa766","article-title":"11\u03b2HSD1 Inhibition with AZD4017 Improves Lipid Profiles and Lean Muscle Mass in Idiopathic Intracranial Hypertension","volume":"106","author":"Hardy","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/s41467-023-36541-w","article-title":"11\u03b2-HSD1 inhibition in men mitigates prednisolone-induced adverse effects in a proof-of-concept randomised double-blind placebo-controlled trial","volume":"14","author":"Othonos","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Vignjevi\u0107, P.S., Milo\u0161evi\u0107, M.S., Markovi\u0107, D., and Mom\u010dilovi\u0107, S. (2023). Interplay between stress and cancer-A focus on inflammation. Front. Physiol., 14.","DOI":"10.3389\/fphys.2023.1119095"},{"key":"ref_50","first-page":"664","article-title":"Glucocorticoids Induce Bone and Muscle Atrophy by Tissue-Specific Mechanisms Upstream of E3 Ubiquitin Ligases","volume":"158","author":"Sato","year":"2017","journal-title":"Endocrinology"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"913","DOI":"10.4103\/2230-8210.117215","article-title":"Glucocorticoid-induced myopathy: Pathophysiology, diagnosis, and treatment","volume":"17","author":"Gupta","year":"2013","journal-title":"Indian. J. Endocrinol. Metab."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1016\/j.biocel.2013.05.036","article-title":"Glucocorticoid-induced skeletal muscle atrophy","volume":"45","author":"Schakman","year":"2013","journal-title":"Int. J. Biochem. Cell. Biol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.mce.2013.03.003","article-title":"Metabolic functions of glucocorticoid receptor in skeletal muscle","volume":"380","author":"Kuo","year":"2013","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1152\/physrev.00031.2010","article-title":"Fiber Types in Mammalian Skeletal Muscles","volume":"91","author":"Schiaffino","year":"2011","journal-title":"Physiol. Rev."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Julien, I.B., Sephton, C.F., and Dutchak, P.A. (2018). Metabolic networks influencing skeletal muscle fiber composition. Front. Cell Dev. Biol., 6.","DOI":"10.3389\/fcell.2018.00125"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1085\/jgp.201210773","article-title":"Intracellular calcium movements during excitation\u2013contraction coupling in mammalian slow-twitch and fast-twitch muscle fibers","volume":"139","author":"Baylor","year":"2012","journal-title":"J. Gen. Physiol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1749-6632.2012.06738.x","article-title":"Role of PGC-1\u03b1 signaling in skeletal muscle health and disease","volume":"1271","author":"Kang","year":"2012","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Komiya, Y., Iseki, S., Ochiai, M., Takahashi, Y., Yokoyama, I., Suzuki, T., Tatsumi, R., Sawano, S., Mizunoya, W., and Arihara, K. (2024). Dietary oleic acid intake increases the proportion of type 1 and 2X muscle fibers in mice. Sci. Rep., 14.","DOI":"10.1038\/s41598-023-50464-y"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Song, P., Zhao, J., Li, F., Zhao, X., Feng, J., Su, Y., Wang, B., and Zhao, J. (2024). Vitamin A regulates mitochondrial biogenesis and function through p38 MAPK-PGC-1\u03b1 signaling pathway and alters the muscle fiber composition of sheep. J. Anim. Sci. Biotechnol., 15.","DOI":"10.1186\/s40104-023-00968-4"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1080\/09168451.2016.1254531","article-title":"PGC-1\u03b1 over-expression suppresses the skeletal muscle atrophy and myofiber-type composition during hindlimb unloading","volume":"81","author":"Wang","year":"2017","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Servais, L., Lair, L.L., Connolly, A.M., Byrne, B.J., Chen, K.S., Coric, V., Qureshi, I., Durham, S., Campbell, D.J., and Maclaine, G. (2024). Taldefgrobep Alfa and the Phase 3 RESILIENT Trial in Spinal Muscular Atrophy. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms251910273"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s40120-023-00570-w","article-title":"The Clinical Development of Taldefgrobep Alfa: An Anti-Myostatin Adnectin for the Treatment of Duchenne Muscular Dystrophy","volume":"13","author":"Muntoni","year":"2024","journal-title":"Neurol. Ther."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Pirruccello-Straub, M., Jackson, J., Wawersik, S., Webster, M.T., Salta, L., Long, K., McConaughy, W., Capili, A., Boston, C., and Carven, G.J. (2018). Blocking extracellular activation of myostatin as a strategy for treating muscle wasting. Sci. Rep., 8.","DOI":"10.1038\/s41598-018-20524-9"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"e209519","DOI":"10.1212\/WNL.0000000000209519","article-title":"Safety and Efficacy of Apitegromab in Patients With Spinal Muscular Atrophy Types 2 and 3: The Phase 2 TOPAZ Study","volume":"103","author":"Crawford","year":"2024","journal-title":"Neurology"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1515\/jbcpp-2024-0065","article-title":"Bimagrumab: An investigational human monoclonal antibody against activin type II receptors for treating obesity","volume":"35","author":"Kaur","year":"2024","journal-title":"J. Basic. Clin. Physiol. Pharmacol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1128\/MCB.01307-13","article-title":"An antibody blocking activin type II receptors induces strong skeletal muscle hypertrophy and protects from atrophy","volume":"34","author":"Minetti","year":"2014","journal-title":"Mol. Cell. Biol."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Vilchinskaya, N., Altaeva, E., and Lomonosova, Y. (2022). Gaining insight into the role of FoxO1 in the progression of disuse-induced skeletal muscle atrophy. Adv. Biol. Regul., 85.","DOI":"10.1016\/j.jbior.2022.100903"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"101187","DOI":"10.1016\/j.molmet.2021.101187","article-title":"FOXO1 inhibition synergizes with FGF21 to normalize glucose control in diabetic mice","volume":"49","author":"Lee","year":"2021","journal-title":"Mol. Metab."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1038\/s41388-019-1044-7","article-title":"A drug library screen identifies Carbenoxolone as novel FOXO inhibitor that overcomes FOXO3-mediated chemoprotection in high-stage neuroblastoma","volume":"39","author":"Salcher","year":"2020","journal-title":"Oncogene"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"e182664","DOI":"10.1172\/jci.insight.182664","article-title":"Pharmacologic or genetic interference with atrogene signaling protects from glucocorticoid-induced musculoskeletal and cardiac disease","volume":"9","author":"Sato","year":"2024","journal-title":"JCI Insight"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"S157","DOI":"10.2337\/dc09-S302","article-title":"Skeletal muscle insulin resistance is the primary defect in type 2 diabetes","volume":"32","author":"DeFronzo","year":"2009","journal-title":"Diabetes. Care"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/978-1-4939-2895-8_5","article-title":"Regulation of glucose homeostasis by glucocorticoids","volume":"872","author":"Kuo","year":"2015","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"R113","DOI":"10.1530\/EJE-21-0553","article-title":"Local and systemic effects of glucocorticoids on metabolism: New lessons from animal models","volume":"185","author":"Swarbrick","year":"2021","journal-title":"Eur. J. Endocrinol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.abb.2016.05.020","article-title":"Dexamethasone rapidly inhibits glucose uptake via non-genomic mechanisms in contracting myotubes","volume":"603","author":"Gong","year":"2016","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_75","first-page":"267","article-title":"PI3 Kinase Regulation of Skeletal Muscle Hypertrophy and Atrophy","volume":"Volume 1","author":"Rommel","year":"2011","journal-title":"Phosphoinositide 3-Kinase in Health and Disease"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Yoon, M.S. (2017). mTOR as a key regulator in maintaining skeletal muscle mass. Front. Physiol., 8.","DOI":"10.3389\/fphys.2017.00788"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"100015","DOI":"10.1016\/j.bneo.2024.100015","article-title":"Central role of the mTORC1 pathway in glucocorticoid activity against B-ALL cells","volume":"1","author":"Imanaga","year":"2024","journal-title":"Blood Neoplasia"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1093\/jmcb\/mjz001","article-title":"Glucocorticoid receptor-IRS-1 axis controls EMT and the metastasis of breast cancers","volume":"11","author":"Shi","year":"2019","journal-title":"J. Mol. Cell. Biol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1128\/MCB.01447-12","article-title":"C1-Ten Is a Protein Tyrosine Phosphatase of Insulin Receptor Substrate 1 (IRS-1), Regulating IRS-1 Stability and Muscle Atrophy","volume":"33","author":"Koh","year":"2013","journal-title":"Mol. Cell. Biol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"7455","DOI":"10.1074\/jbc.272.11.7455","article-title":"Specific Increase in p85\u03b1 Expression in Response to Dexamethasone Is Associated with Inhibition of Insulin-like Growth Factor-I Stimulated Phosphatidylinositol 3-Kinase Activity in Cultured Muscle Cells","volume":"272","author":"Giorgino","year":"1997","journal-title":"J. Biol. Chem."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"11160","DOI":"10.1073\/pnas.1111334109","article-title":"Genome-wide analysis of glucocorticoid receptor-binding sites in myotubes identifies gene networks modulating insulin signaling","volume":"109","author":"Kuo","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"6663","DOI":"10.1074\/jbc.M112.390369","article-title":"Muscle-specific MicroRNA1 (miR1) Targets Heat Shock Protein 70 (HSP70) during Dexamethasone-mediated Atrophy","volume":"288","author":"Kukreti","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1038\/s12276-023-01056-3","article-title":"The stress-responsive protein REDD1 and its pathophysiological functions","volume":"55","author":"Kim","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1074\/jbc.M114.623058","article-title":"Regulated in Development and DNA Damage 1 Is Necessary for Hyperglycemia-induced Vascular Endothelial Growth Factor Expression in the Retina of Diabetic Rodents","volume":"290","author":"Dennis","year":"2015","journal-title":"J. Biol. Chem."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.2337\/dbi24-0013","article-title":"REDD1 is a Promising Therapeutic Target to Combat the Development of Diabetic Complications: A Report on Research Supported by Pathway to Stop Diabetes","volume":"73","author":"Sunilkumar","year":"2024","journal-title":"Diabetes"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1021\/bi902135e","article-title":"Structural analysis and functional implications of the negative mTORC1 regulator REDD1","volume":"49","author":"Abdallah","year":"2010","journal-title":"Biochemistry"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"42","DOI":"10.15252\/emmm.201404601","article-title":"REDD 1 functions at the crossroads between the therapeutic and adverse effects of topical glucocorticoids","volume":"7","author":"Baida","year":"2015","journal-title":"EMBO Mol. Med."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"E983","DOI":"10.1152\/ajpendo.00234.2014","article-title":"REDD1 deletion prevents dexamethasone-induced skeletal muscle atrophy","volume":"307","author":"Britto","year":"2014","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1016\/j.jid.2018.02.045","article-title":"Rapamycin Modulates Glucocorticoid Receptor Function, Blocks Atrophogene REDD1, and Protects Skin from Steroid Atrophy HHS Public Access","volume":"138","author":"Lesovaya","year":"2018","journal-title":"J. Investig. Dermatol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.ebiom.2019.01.055","article-title":"PI3K inhibitors protect against glucocorticoid-induced skin atrophy","volume":"41","author":"Agarwal","year":"2019","journal-title":"EBioMedicine"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1158\/1535-7163.MCT-19-1111","article-title":"A novel approach to safer glucocorticoid receptor\u2013targeted anti-lymphoma therapy via REDD1 (regulated in development and DNA damage 1) inhibition","volume":"19","author":"Lesovaya","year":"2020","journal-title":"Mol. Cancer Ther."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1021\/cb400789e","article-title":"The Commonly Used PI3-Kinase Probe LY294002 Is an Inhibitor of BET Bromodomains","volume":"9","author":"Dittmann","year":"2014","journal-title":"ACS Chem. Biol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"3693","DOI":"10.1093\/emboj\/16.12.3693","article-title":"Rapamycin Suppresses 5\u2032 TOP mRNA Translation through Inhibition of p70S6k","volume":"16","author":"Jefferies","year":"1997","journal-title":"EMBO J."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1128\/MCB.00980-08","article-title":"The TSC-mTOR Pathway Mediates Translational Activation of TOP mRNAs by Insulin Largely in a Raptor- or Rictor-Independent Manner","volume":"29","author":"Kasir","year":"2009","journal-title":"Mol. Cell. Biol."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Zhang, S., Zeng, X., Ren, M., Mao, X., and Qiao, S. (2017). Novel metabolic and physiological functions of branched chain amino acids: A review. J. Anim. Sci. Biotechnol., 8.","DOI":"10.1186\/s40104-016-0139-z"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1152\/japplphysiol.01484.2011","article-title":"An amino acid mixture is essential to optimize insulin-stimulated glucose uptake and GLUT4 translocation in perfused rodent hindlimb muscle","volume":"113","author":"Bernard","year":"2012","journal-title":"J. Appl. Physiol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"G1292","DOI":"10.1152\/ajpgi.00510.2003","article-title":"Branched-chain amino acids improve glucose metabolism in rats with liver cirrhosis","volume":"288","author":"Nishitani","year":"2004","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.bbrc.2003.11.039","article-title":"Isoleucine, a potent plasma glucose-lowering amino acid, stimulates glucose uptake in C2C12 myotubes","volume":"312","author":"Doi","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1093\/jn\/129.6.1102","article-title":"Leucine Supplementation Enhances Skeletal Muscle Recovery in Rats Following Exercise12","volume":"129","author":"Anthony","year":"1999","journal-title":"J. Nutr."},{"key":"ref_100","first-page":"222","article-title":"Leucine-enriched nutrients and the regulation of mammalian target of rapamycin signalling and human skeletal muscle protein synthesis","volume":"11","author":"Drummond","year":"2008","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1152\/ajpendo.00413.2004","article-title":"Combined ingestion of protein and free leucine with carbohydrate increases postexercise muscle protein synthesis in vivo in male subjects","volume":"288","author":"Koopman","year":"2005","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1093\/jn\/130.10.2413","article-title":"Leucine stimulates translation Initiation in skeletal muscle of postabsorptive rats via a rapamycin-sensitive pathway","volume":"130","author":"Anthony","year":"2000","journal-title":"J. Nutr."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/jn\/130.2.139","article-title":"Orally administered leucine stimulates protein synthesis in skeletal muscle of postabsorptive rats in association with Increased eIF4F Formation","volume":"130","author":"Anthony","year":"2000","journal-title":"J. Nutr."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/asj.12520","article-title":"Effects of dietary leucine supplementation in low crude protein diets on performance, nitrogen balance, whole-body protein turnover, carcass characteristics and meat quality of finishing pigs","volume":"87","author":"Zhang","year":"2016","journal-title":"Anim. Sci. J."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"7063","DOI":"10.3168\/jds.2024-25751","article-title":"Meta-analysis of the effects of supplemental leucine alone or in combination with other branched-chain amino acids on lactational performance in dairy cows and the associated influencing factors","volume":"108","author":"Wang","year":"2025","journal-title":"J. Dairy Sci."},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Santoyo-Suarez, M.G., Mares-Montemayor, J.D., Padilla-Rivas, G.R., Delgado-Gallegos, J.L., Quiroz-Reyes, A.G., Roacho-Perez, J.A., Benitez-Chao, D.F., Garza-Oca\u00f1as, L., Arevalo-Martinez, G., and Garza-Trevi\u00f1o, E.N. (2023). The Involvement of Kr\u00fcppel-like Factors in Cardiovascular Diseases. Life, 13.","DOI":"10.3390\/life13020420"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yjmcc.2007.04.005","article-title":"Kruppel-like Factors (KLFs) in muscle biology","volume":"43","author":"Haldar","year":"2007","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Leenders, J.J., Wijnen, W.J., van der Made, I., Hiller, M., Swinnen, M., Vandendriessche, T., Chuah, M., Pinto, Y.M., and Creemers, E.E. (2012). Repression of cardiac hypertrophy by KLF15: Underlying mechanisms and therapeutic implications. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0036754"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.diabres.2018.05.041","article-title":"Role of serum myostatin in the association between hyperinsulinemia and muscle atrophy in Japanese obese patients","volume":"142","author":"Tanaka","year":"2018","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1161\/STROKEAHA.114.008574","article-title":"Molecular mechanisms of skeletal muscle atrophy in a mouse model of cerebral ischemia","volume":"46","author":"Desgeorges","year":"2015","journal-title":"Stroke"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1146\/annurev-physiol-012422-112116","article-title":"Myostatin: A Skeletal muscle chalone","volume":"85","author":"Lee","year":"2023","journal-title":"Annu. Rev. Physiol."},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Bish, L.T., Morine, K.J., Sleeper, M.M., and Sweeney, H.L. (2010). Myostatin is upregulated following stress in an Erk-dependent manner and negatively regulates cardiomyocyte growth in culture and in a mouse model. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0010230"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13395-015-0063-5","article-title":"Investigating mechanisms underpinning the detrimental impact of a high-fat diet in the developing and adult hypermuscular myostatin null mouse","volume":"5","author":"Matsakas","year":"2015","journal-title":"Skelet. Muscle"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"12184","DOI":"10.1074\/jbc.M115.680579","article-title":"Smad2\/3 Proteins are required for immobilization-induced skeletal muscle atrophy","volume":"291","author":"Tando","year":"2016","journal-title":"J. Biol. Chem."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/jcp.21325","article-title":"Identification of the gene transcription and apoptosis mediated by TGF-\u03b2-Smad2\/3-Smad4 signaling","volume":"215","author":"Yu","year":"2008","journal-title":"J. Cell. Physiol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"407","DOI":"10.23876\/j.krcp.19.085","article-title":"Activin\/myostatin receptor signaling and vascular calcifications in chronic kidney disease: A \u201cliaison dangereuse\u201d?","volume":"38","author":"Garibotto","year":"2019","journal-title":"Kidney. Res. Clin. Pract."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1210\/en.2008-0959","article-title":"Down-regulation of AKT\/mammalian target of rapamycin signaling pathway in response to myostatin overexpression in skeletal muscle","volume":"150","author":"Amirouche","year":"2009","journal-title":"Endocrinology"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.biocel.2013.12.003","article-title":"Myostatin signaling regulates AKT activity via the regulation of miR-486 expression","volume":"47","author":"Hitachi","year":"2014","journal-title":"Int. J. Biochem. Cell. Biol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1007\/s11010-024-05027-8","article-title":"miR-486-5p diagnosed atrial fibrillation, predicted the risk of left atrial fibrosis, and regulated angiotensin II-induced cardiac fibrosis via modulating PI3K\/AKT signaling through targeting FOXO1","volume":"480","author":"Zhang","year":"2025","journal-title":"Mol. Cell. Biochem."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"C1258","DOI":"10.1152\/ajpcell.00105.2009","article-title":"Myostatin reduces AKT\/TORC1\/p70S6K signaling, inhibiting myoblast differentiation and myotube size","volume":"296","author":"Trendelenburg","year":"2009","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/s00018-022-04408-w","article-title":"Inhibition of myostatin and related signaling pathways for the treatment of muscle atrophy in motor neuron diseases","volume":"79","author":"Abati","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"40235","DOI":"10.1074\/jbc.M004356200","article-title":"Myostatin, a negative regulator of muscle growth, functions by inhibiting myoblast proliferation","volume":"275","author":"Thomas","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"E363","DOI":"10.1152\/ajpendo.00487.2002","article-title":"Glucocorticoid-induced skeletal muscle atrophy is associated with upregulation of myostatin gene expression","volume":"285","author":"Ma","year":"2003","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1210\/en.2006-0539","article-title":"Myostatin gene deletion prevents glucocorticoid-induced muscle atrophy","volume":"148","author":"Gilson","year":"2007","journal-title":"Endocrinology"},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Wang, R., Jiao, H., Zhao, J., Wang, X., and Lin, H. (2016). Glucocorticoids enhance muscle proteolysis through a myostatin-dependent pathway at the early stage. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0156225"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1","DOI":"10.17987\/jcsm-cr.v2i1.37","article-title":"Myostatin inhibitors as pharmacological treatment for muscle wasting and muscular dystrophy","volume":"2","author":"Saitoh","year":"2017","journal-title":"JCSM Clin. Rep."},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Jang, J.Y., Kim, D., and Kim, N.D. (2023). Pathogenesis, intervention, and current status of drug development for sarcopenia: A Review. Biomedicines, 11.","DOI":"10.3390\/biomedicines11061635"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/WCO.0000000000000853","article-title":"The elusive promise of myostatin inhibition for muscular dystrophy","volume":"33","author":"Wagner","year":"2020","journal-title":"Curr. Opin. Neurol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"151","DOI":"10.11005\/jbm.2020.27.3.151","article-title":"Myostatin inhibitors: Panacea or predicament for musculoskeletal misorders?","volume":"27","author":"Suh","year":"2020","journal-title":"J. Bone. Metab."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"e133276","DOI":"10.1172\/jci.insight.133276","article-title":"Glucocorticoids counteract hypertrophic effects of myostatin inhibition in dystrophic muscle","volume":"5","author":"Hammers","year":"2020","journal-title":"JCI Insight"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1164\/rccm.201802-0286OC","article-title":"Activin type II receptor blockade for treatment of muscle depletion in chronic obstructive pulmonary disease: A randomized trial","volume":"199","author":"Polkey","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1177\/87551225251317957","article-title":"Sotatercept: A First-In-Class Activin Signaling Inhibitor for Pulmonary Arterial Hypertension","volume":"41","author":"Miranda","year":"2025","journal-title":"J. Pharm. Technol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.tips.2022.09.010","article-title":"FOXO transcription factors as therapeutic targets in human diseases","volume":"43","author":"Paik","year":"2022","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Asadi, Y., Moundounga, R.K., Chakroborty, A., Pokokiri, A., and Wang, H. (2025). FOXOs and their roles in acute and chronic neurological disorders. Front. Mol. Biosci., 12.","DOI":"10.3389\/fmolb.2025.1538472"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"6670","DOI":"10.1038\/ncomms7670","article-title":"Regulation of autophagy and the ubiquitin\u2013proteasome system by the FoxO transcriptional network during muscle atrophy","volume":"6","author":"Milan","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.cmet.2007.11.004","article-title":"FoxO3 Coordinately Activates Protein Degradation by the Autophagic\/Lysosomal and Proteasomal Pathways in Atrophying Muscle Cells","volume":"6","author":"Zhao","year":"2007","journal-title":"Cell Metab."},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"L\u00fctzner, N., Kalbacher, H., Krones-Herzig, A., and R\u00f6sl, F. (2012). FOXO3 is a glucocorticoid receptor target and regulates LKB1 and its own expression based on cellular AMP levels via a positive autoregulatory loop. PLoS ONE., 7.","DOI":"10.1371\/journal.pone.0042166"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.bbrc.2014.06.080","article-title":"Identification of functional glucocorticoid response elements in the mouse FoxO1 promoter","volume":"450","author":"Qin","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"e27955","DOI":"10.7554\/eLife.27955","article-title":"The Calcineurin-FoxO-MuRF1 signaling pathway regulates myofibril integrity in cardiomyocytes","volume":"6","author":"Shimizu","year":"2017","journal-title":"Elife."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0092-8674(00)80595-4","article-title":"AKT Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor","volume":"96","author":"Brunet","year":"1999","journal-title":"Cell"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S1097-2765(04)00211-4","article-title":"The IGF-1\/PI3K\/AKT pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription fFactors","volume":"14","author":"Stitt","year":"2004","journal-title":"Mol. Cell"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"13402","DOI":"10.1074\/jbc.M010042200","article-title":"Phosphatidylinositol 3-kinase signaling inhibits DAF-16 DNA binding and function via 14-3-3-dependent and 14-3-3-independent Pathways","volume":"276","author":"Cahill","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"19900","DOI":"10.1074\/jbc.M116.728840","article-title":"Blunting autoantigen-induced FOXO3a protein phosphorylation and degradation is a novel pathway of glucocorticoids for the treatment of systemic lupus erythematosus","volume":"291","author":"Lu","year":"2016","journal-title":"J. Biol. Chem."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"C278","DOI":"10.1152\/ajpcell.00391.2013","article-title":"SMAD3 augments FoxO3-induced MuRF-1 promoter activity in a DNA-binding-dependent manner","volume":"307","author":"Bollinger","year":"2014","journal-title":"Am. J. Physiol. Cell. Physiol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0092-8674(04)00400-3","article-title":"Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy","volume":"117","author":"Sandri","year":"2004","journal-title":"Cell"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1152\/ajpcell.00315.2009","article-title":"FOXO signaling is required for disuse muscle atrophy and is directly regulated by Hsp70","volume":"298","author":"Senf","year":"2010","journal-title":"Am. J. Physiol. Cell. Physiol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"E785","DOI":"10.1152\/ajpendo.00646.2007","article-title":"The glucocorticoid receptor and FOXO1 synergistically activate the skeletal muscle atrophy-associated MuRF1 gene","volume":"295","author":"Waddell","year":"2008","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/s41467-020-20123-1","article-title":"Mechanisms of muscle atrophy and hypertrophy: Implications in health and disease","volume":"12","author":"Sartori","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_149","doi-asserted-by":"crossref","unstructured":"Judge, S.M., Wu, C.L., Beharry, A.W., Roberts, B.M., Ferreira, L.F., Kandarian, S.C., and Judge, A.R. (2014). Genome-wide identification of FoxO-dependent gene networks in skeletal muscle during C26 cancer cachexia. BMC Cancer, 14.","DOI":"10.1186\/1471-2407-14-997"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.cmet.2007.11.001","article-title":"FoxO3 Controls Autophagy in Skeletal Muscle In Vivo","volume":"6","author":"Mammucari","year":"2007","journal-title":"Cell Metab."},{"key":"ref_151","doi-asserted-by":"crossref","unstructured":"Nakashima, R., Hosoda, R., Tatekoshi, Y., Iwahara, N., Saga, Y., and Kuno, A. (2024). Transcriptional dysregulation of autophagy in the muscle of a mouse model of Duchenne muscular dystrophy. Sci. Rep., 14.","DOI":"10.1038\/s41598-024-51746-9"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"5325","DOI":"10.1242\/jcs.114041","article-title":"Misregulation of autophagy and protein degradation systems in myopathies and muscular dystrophies","volume":"126","author":"Sandri","year":"2013","journal-title":"J. Cell Sci."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1007\/s00018-013-1513-z","article-title":"FoxO transcription factors: Their roles in the maintenance of skeletal muscle homeostasis","volume":"71","author":"Sanchez","year":"2014","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1158\/1541-7786.MCR-15-0127","article-title":"FOXO3a and posttranslational modifications mediate glucocorticoid sensitivity in B-ALL","volume":"13","author":"Consolaro","year":"2015","journal-title":"Mol. Cancer Res."},{"key":"ref_155","doi-asserted-by":"crossref","unstructured":"Pang, X.S., Zhang, P., Chen, X.P., and Liu, W.M. (2023). Ubiquitin-proteasome pathway in skeletal muscle atrophy. Front. Physiol., 14.","DOI":"10.3389\/fphys.2023.1289537"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00424-010-0919-9","article-title":"The role and regulation of MAFbx\/atrogin-1 and MuRF1 in skeletal muscle atrophy","volume":"461","author":"Foletta","year":"2011","journal-title":"Pflugers Arch."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1161\/CIRCRESAHA.114.305393","article-title":"Angiotensin II induces skeletal muscle atrophy by activating TFEB-mediated MuRF1 expression","volume":"117","author":"Lodka","year":"2015","journal-title":"Circ. Res."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/jcsm.12249","article-title":"A muscle-specific MuRF1-E2 network requires stabilization of MuRF1-E2 complexes by telethonin, a newly identified substrate","volume":"9","author":"Polge","year":"2018","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1165\/rcmb.2020-0449OC","article-title":"RANKL mediates muscle atrophy and dysfunction in a cigarette smoke-induced model of chronic obstructive pulmonary disease","volume":"64","author":"Xiong","year":"2021","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1038\/emboj.2008.52","article-title":"The initiation factor eIF3-f is a major target for Atrogin1\/MAFbx function in skeletal muscle atrophy","volume":"27","author":"Offner","year":"2008","journal-title":"EMBO J."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1089\/hum.2010.057","article-title":"Inhibition of Atrogin-1\/MAFbx Expression by Adenovirus-Delivered Small Hairpin RNAs Attenuates Muscle Atrophy in Fasting Mice","volume":"22","author":"Cong","year":"2010","journal-title":"Hum. Gene Ther."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"E501","DOI":"10.1152\/ajpendo.00359.2006","article-title":"Hormone, cytokine, and nutritional regulation of sepsis-induced increases in atrogin-1 and MuRF1 in skeletal muscle","volume":"292","author":"Frost","year":"2007","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1002\/jcb.23093","article-title":"C\/EBP\u03b2 regulates dexamethasone-induced muscle cell atrophy and expression of atrogin-1 and MuRF1","volume":"112","author":"Gonnella","year":"2011","journal-title":"J. Cell. Biochem."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"A92","DOI":"10.1016\/j.krcp.2012.04.625","article-title":"Calcineurin-NFAT signaling regulates atrogin-1 and MuRF1 via miR-23a during glucocorticoid induced muscle atrophy","volume":"31","author":"Hudson","year":"2012","journal-title":"Kidney. Res. Clin. Pract."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"38456","DOI":"10.1074\/jbc.M111.271270","article-title":"Translational suppression of atrophic regulators by miR-23a integrates resistance to skeletal muscle atrophy","volume":"286","author":"Wada","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"RP89381","DOI":"10.7554\/eLife.89381","article-title":"The reciprocal regulation between mitochondrial-associated membranes and Notch signaling in skeletal muscle atrophy","volume":"12","author":"Ito","year":"2023","journal-title":"Elife"},{"key":"ref_167","doi-asserted-by":"crossref","unstructured":"Almowallad, S., Alqahtani, L.S., and Mobashir, M. (2022). NF-kB in signaling patterns and its temporal dynamics encode\/decode human diseases. Life, 12.","DOI":"10.3390\/life12122012"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1182\/blood-2021-147551","article-title":"Disrupting ectopic super-enhancers to treat multiple myeloma","volume":"138","author":"Welsh","year":"2021","journal-title":"Blood"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"e13014","DOI":"10.14814\/phy2.13014","article-title":"Glucocorticoids increase skeletal muscle NF-\u03baB inducing kinase (NIK): Links to muscle atrophy","volume":"4","author":"Fry","year":"2016","journal-title":"Physiol. Rep."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s12576-011-0175-6","article-title":"Differential gene expression of muscle-specific ubiquitin ligase MAFbx\/Atrogin-1 and MuRF1 in response to immobilization-induced atrophy of slow-twitch and fast-twitch muscles","volume":"61","author":"Okamoto","year":"2011","journal-title":"J. Physiol. Sci."},{"key":"ref_171","doi-asserted-by":"crossref","unstructured":"Latham, C.M., Brightwell, C.R., Keeble, A.R., Munson, B.D., Thomas, N.T., Zagzoog, A.M., Fry, C.S., and Fry, J.L. (2021). Vitamin D promotes skeletal muscle regeneration and mitochondrial health. Front. Physiol., 12.","DOI":"10.3389\/fphys.2021.660498"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1113\/JP280652","article-title":"The mechanisms of skeletal muscle atrophy in response to transient knockdown of the vitamin D receptor in vivo","volume":"599","author":"Bass","year":"2021","journal-title":"J. Physiol."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1096\/fj.201601294R","article-title":"Pharmacological Sirt6 inhibition improves glucose tolerance in a type 2 diabetes mouse model","volume":"31","author":"Sociali","year":"2017","journal-title":"FASEB J."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/s41392-020-00391-5","article-title":"GSK-LSD1, an LSD1 inhibitor, quashes SARS-CoV-2-triggered cytokine release syndrome in-vitro","volume":"5","author":"Hong","year":"2020","journal-title":"Signal. Transduct. Target. Ther."},{"key":"ref_175","doi-asserted-by":"crossref","unstructured":"Wirthgen, E., Leonard, A.K., Scharf, C., and Domanska, G. (2020). The immunomodulator 1-Methyltryptophan drives tryptophan catabolism toward the kynurenic acid branch. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.00313"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1002\/jcsm.13193","article-title":"Interleukin-6 promotes skeletal muscle catabolism by activating tryptophan\u2013indoleamine 2,3-dioxygenase 1\u2013kynurenine pathway during intra-abdominal sepsis","volume":"14","author":"Xie","year":"2023","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1158\/1078-0432.CCR-18-2740","article-title":"Phase I Study of the Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitor Navoximod (GDC-0919) Administered with PD-L1 Inhibitor (Atezolizumab) in Advanced Solid Tumors","volume":"25","author":"Jung","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"9732","DOI":"10.1021\/acs.jmedchem.1c00601","article-title":"Emerging Therapeutic Potential of SIRT6 Modulators","volume":"64","author":"Fiorentino","year":"2021","journal-title":"J. Med. Chem."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S2468-1253(24)00248-6","article-title":"Safety, clinical activity, pharmacodynamics, and pharmacokinetics of IMU-856, a SIRT6 modulator, in coeliac disease: A first-in-human, randomised, double-blind, placebo-controlled, phase 1 trial","volume":"10","author":"Daveson","year":"2025","journal-title":"Lancet Gastrooenterol. Hepatol."},{"key":"ref_180","doi-asserted-by":"crossref","unstructured":"Li, Y., Jin, J., and Wang, Y. (2022). SIRT6 widely regulates aging, immunity, and cancer. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.861334"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.cell.2005.11.044","article-title":"Genomic instability and aging-like phenotype in the absence of mammalian SIRT6","volume":"124","author":"Mostoslavsky","year":"2006","journal-title":"Cell"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/nature10815","article-title":"The sirtuin SIRT6 regulates lifespan in male mice","volume":"483","author":"Kanfi","year":"2012","journal-title":"Nature"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.1038\/s41467-021-23545-7","article-title":"Restoration of energy homeostasis by SIRT6 extends healthy lifespan","volume":"12","author":"Roichman","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1038\/nm.2961","article-title":"The sirtuin SIRT6 blocks IGF-AKT signaling and development of cardiac hypertrophy by targeting c-Jun","volume":"18","author":"Sundaresan","year":"2012","journal-title":"Nat. Med."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"4796","DOI":"10.1021\/jm500487d","article-title":"Discovery of novel and selective SIRT6 inhibitors","volume":"57","author":"Parenti","year":"2014","journal-title":"J. Med. Chem."},{"key":"ref_186","doi-asserted-by":"crossref","unstructured":"Rahnasto-Rilla, M., Tyni, J., Huovinen, M., Jarho, E., Kulikowicz, T., Ravichandran, S., A Bohr, V., Ferrucci, L., Lahtela-Kakkonen, M., and Moaddel, R. (2018). Natural polyphenols as sirtuin 6 modulators. Sci. Rep., 8.","DOI":"10.1038\/s41598-018-22388-5"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1038\/s41467-022-29472-5","article-title":"Sirt6 reprograms myofibers to oxidative type through CREB-dependent Sox6 suppression","volume":"13","author":"Song","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"4184","DOI":"10.1038\/s41467-022-31798-z","article-title":"Inactivation of Sirt6 ameliorates muscular dystrophy in mdx mice by releasing suppression of utrophin expression","volume":"13","author":"Georgieva","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.2217\/epi-2016-0009","article-title":"LSD1: Biologic roles and therapeutic targeting","volume":"8","author":"Somervaille","year":"2016","journal-title":"Epigenomics"},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1038\/s12276-020-00542-2","article-title":"LSD1: More than demethylation of histone lysine residues","volume":"52","author":"Perillo","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature04020","article-title":"LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription","volume":"437","author":"Metzger","year":"2005","journal-title":"Nature"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"11040","DOI":"10.1093\/nar\/gku823","article-title":"Mechanism of retinoic acid-induced transcription: Histone code, DNA oxidation and formation of chromatin loops","volume":"42","author":"Zuchegna","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1101\/gad.552910","article-title":"Cooperative interaction between retinoic acid receptor-\u03b1 and estrogen receptor in breast cancer","volume":"24","author":"Stark","year":"2010","journal-title":"Genes Dev."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1101\/gad.215293.113","article-title":"Unliganded progesterone receptormediated targeting of an RNA-containing repressive complex silences a subset of hormone-inducible genes","volume":"27","author":"Vicent","year":"2013","journal-title":"Genes Dev."},{"key":"ref_195","doi-asserted-by":"crossref","unstructured":"Noce, B., Di Bello, E., Fioravanti, R., and Mai, A. (2023). LSD1 inhibitors for cancer treatment: Focus on multi-target agents and compounds in clinical trials. Front. Pharmacol., 14.","DOI":"10.3389\/fphar.2023.1120911"},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1021\/acsptsci.1c00223","article-title":"Comprehensive in Vitro Characterization of the LSD1 Small Molecule Inhibitor Class in Oncology","volume":"4","author":"Sacilotto","year":"2021","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"ref_197","doi-asserted-by":"crossref","unstructured":"Yang, Y., Liu, X., Liu, X., Xie, C., and Shi, J. (2024). The role of the kynurenine pathway in cardiovascular disease. Front. Cardiovasc. Med., 11.","DOI":"10.3389\/fcvm.2024.1406856"},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.7150\/jca.31727","article-title":"Role of IDO and TDO in cancers and related diseases and the therapeutic implications","volume":"10","author":"Ye","year":"2019","journal-title":"J. Cancer"},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"111890","DOI":"10.1016\/j.mad.2023.111890","article-title":"Relation of the kynurenine pathway with normal age: A systematic review","volume":"217","author":"Bakker","year":"2024","journal-title":"Mech. Ageing Dev."},{"key":"ref_200","doi-asserted-by":"crossref","unstructured":"Tsuji, A., Ikeda, Y., Yoshikawa, S., Taniguchi, K., Sawamura, H., Morikawa, S., Nakashima, M., Asai, T., and Matsuda, S. (2023). The tryptophan and kynurenine pathway involved in the development of immune-related diseases. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24065742"},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"110797","DOI":"10.1016\/j.exger.2019.110797","article-title":"Kynurenine signaling through the aryl hydrocarbon receptor: Implications for aging and healthspan","volume":"130","author":"Kaiser","year":"2020","journal-title":"Exp. Gerontol."},{"key":"ref_202","doi-asserted-by":"crossref","unstructured":"Ballesteros, J., Rivas, D., and Duque, G. (2023). The role of the kynurenine pathway in the pathophysiology of frailty, sarcopenia, and osteoporosis. Nutrients, 15.","DOI":"10.20944\/preprints202305.1990.v1"},{"key":"ref_203","doi-asserted-by":"crossref","unstructured":"Ritz, J., Wunderle, C., Stumpf, F., Laager, R., Tribolet, P., Neyer, P., Bernasconi, L., Stanga, Z., Mueller, B., and Schuetz, P. (2024). Association of tryptophan pathway metabolites with mortality and effectiveness of nutritional support among patients at nutritional risk: Secondary analysis of a randomized clinical trial. Front. Nutr., 11.","DOI":"10.3389\/fnut.2024.1335242"},{"key":"ref_204","first-page":"551","article-title":"A structural role for tryptophan in proteins, and the ubiquitous Trp C\u03b41-H\u2026O C (backbone) hydrogen bond","volume":"80","author":"Szczygiel","year":"2024","journal-title":"Biol. Crystallogr."},{"key":"ref_205","doi-asserted-by":"crossref","unstructured":"Zhao, D., Yu, Y., Shen, Y., Liu, Q., Zhao, Z., Sharma, R., and Reiter, R.J. (2019). Melatonin synthesis and function: Evolutionary history in animals and plants. Front. Endocrinol., 10.","DOI":"10.3389\/fendo.2019.00249"},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"IJTR-S11588","DOI":"10.4137\/IJTR.S11588","article-title":"Nutritional aspect of tryptophan metabolism","volume":"6","author":"Fukuwatari","year":"2013","journal-title":"Int. J. Tryptophan. Res."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1017\/S0007114521002828","article-title":"Effects of dietary tryptophan on muscle growth, protein synthesis and antioxidant capacity in hybrid catfish Pelteobagrus vachelli\u2640 \u00d7 Leiocassis longirostris\u2642","volume":"127","author":"Jiang","year":"2022","journal-title":"Br. J. Nutr."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.nut.2015.02.011","article-title":"The aromatic amino acid tryptophan stimulates skeletal muscle IGF1\/p70s6k\/mTor signaling in vivo and the expression of myogenic genes in vitro","volume":"31","author":"Dukes","year":"2015","journal-title":"Nutrition"},{"key":"ref_209","doi-asserted-by":"crossref","unstructured":"Ninomiya, S., Nakamura, N., Nakamura, H., Mizutani, T., Kaneda, Y., Yamaguchi, K., Matsumoto, T., Kitagawa, J., Kanemura, N., and Shiraki, M. (2020). Low levels of serum tryptophan underlie skeletal muscle atrophy. Nutrients, 12.","DOI":"10.3390\/nu12040978"},{"key":"ref_210","doi-asserted-by":"crossref","unstructured":"Agull\u00f3-Ortu\u00f1o, M.T., Mancebo, E., Grau, M., N\u00fa\u00f1ez Sobrino, J.A., Paz-Ares, L., L\u00f3pez-Mart\u00edn, J.A., and Fl\u00e1ndez, M. (2023). Tryptophan modulation in cancer-associated cachexia mouse models. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241613005"},{"key":"ref_211","doi-asserted-by":"crossref","unstructured":"Takeshita, H., and Yamamoto, K. (2022). Tryptophan metabolism and COVID-19-induced skeletal muscle damage: Is ACE2 a key regulator?. Front. Nutr., 9.","DOI":"10.3389\/fnut.2022.868845"},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"9894238","DOI":"10.1155\/2019\/9894238","article-title":"Kynurenine, a Tryptophan metabolite that increases with Age, Induces Muscle Atrophy and Lipid Peroxidation","volume":"2019","author":"Kaiser","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_213","doi-asserted-by":"crossref","unstructured":"Palzkill, V.R., Thome, T., Murillo, A.L., Khattri, R.B., and Ryan, T.E. (2022). Increasing plasma L-kynurenine impairs mitochondrial oxidative phosphorylation prior to the development of atrophy in murine skeletal muscle: A pilot study. Front. Physiol., 13.","DOI":"10.3389\/fphys.2022.992413"},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"11786469231185102","DOI":"10.1177\/11786469231185102","article-title":"The role of the kynurenine\/AhR pathway in diseases related to metabolism and cancer","volume":"16","author":"Shadboorestan","year":"2023","journal-title":"Int. J. Tryptophan. Res."},{"key":"ref_215","doi-asserted-by":"crossref","unstructured":"Wirthgen, E., Hoeflich, A., Rebl, A., and G\u00fcnther, J. (2018). Kynurenic Acid: The Janus-faced role of an immunomodulatory tryptophan metabolite and its link to pathological conditions. Front. Immunol., 8.","DOI":"10.3389\/fimmu.2017.01957"},{"key":"ref_216","doi-asserted-by":"crossref","unstructured":"Zhen, D., Liu, J., Zhang, X.D., and Song, Z. (2022). Kynurenic acid acts as a signaling molecule regulating energy expenditure and is closely associated with metabolic diseases. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.847611"},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"110880","DOI":"10.1016\/j.exger.2020.110880","article-title":"Kynurenine aminotransferase isoforms display fiber-type specific expression in young and old human skeletal muscle","volume":"134","author":"Wyckelsma","year":"2020","journal-title":"Exp. Gerontol."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1038\/s41467-019-10712-0","article-title":"Skeletal muscle PGC-1\u03b11 reroutes kynurenine metabolism to increase energy efficiency and fatigue-resistance","volume":"10","author":"Agudelo","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_219","doi-asserted-by":"crossref","unstructured":"Saran, T., Turska, M., Kocki, T., Zawadka, M., Zieli\u0144ski, G., Turski, W.A., and Gawda, P. (2021). Effect of 4-week physical exercises on tryptophan, kynurenine and kynurenic acid content in human sweat. Sci. Rep., 11.","DOI":"10.1038\/s41598-021-90616-6"},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"e13921","DOI":"10.1111\/apha.13921","article-title":"Tissue-specific effects of exercise as NAD+-boosting strategy: Current knowledge and future perspectives","volume":"237","author":"Walzik","year":"2023","journal-title":"Acta Physiol."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1161\/CIRCRESAHA.114.302113","article-title":"Activation of NAD(P)H Oxidase by Tryptophan-Derived 3-Hydroxykynurenine Accelerates Endothelial Apoptosis and Dysfunction In Vivo","volume":"114","author":"Wang","year":"2014","journal-title":"Circ. Res."},{"key":"ref_222","doi-asserted-by":"crossref","unstructured":"Malina, H.Z., and Hess, O.M. (2004). Xanthurenic acid translocates proapoptotic Bcl-2 family proteins into mitochondria and impairs mitochondrial function. BMC Cell Biol., 5.","DOI":"10.1186\/1471-2121-5-14"},{"key":"ref_223","first-page":"104024","article-title":"Quinolinic acid: An endogenous neurotoxin with multiple targets","volume":"2013","author":"Pineda","year":"2013","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1002\/jbmr.4125","article-title":"Picolinic acid, a catabolite of tryptophan, has an anabolic effect on bone in vivo","volume":"35","author":"Duque","year":"2020","journal-title":"J. Bone Miner. Res."},{"key":"ref_225","doi-asserted-by":"crossref","unstructured":"Hestad, K., Alexander, J., Rootwelt, H., and Aaseth, J.O. (2022). The role of tryptophan dysmetabolism and quinolinic acid in depressive and neurodegenerative diseases. Biomolecules, 12.","DOI":"10.3390\/biom12070998"},{"key":"ref_226","doi-asserted-by":"crossref","unstructured":"Hetherington-Rauth, M., Johnson, E., Migliavacca, E., Langsetmo, L., Hepple, R.T., Ryan, T.E., Ferrucci, L., Breuill\u00e9, D., Corthesy, J., and Lane, N.E. (2024). The mediating role of kynurenine pathway metabolites on the relationship between inflammation and muscle mass in oldest\u2013old Men. J. Gerontol. A Biol. Sci. Med. Sci., 79.","DOI":"10.1093\/gerona\/glae131"},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"1178646917691938","DOI":"10.1177\/1178646917691938","article-title":"Kynurenine pathway of tryptophan metabolism: Regulatory and functional aspects","volume":"10","author":"Badawy","year":"2017","journal-title":"Int. J. Tryptophan. Res."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"C818","DOI":"10.1152\/ajpcell.00580.2019","article-title":"The kynurenine connection: How exercise shifts muscle tryptophan metabolism and affects energy homeostasis, the immune system, and the brain","volume":"318","author":"Martin","year":"2020","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"11786469211069951","DOI":"10.1177\/11786469211069951","article-title":"Association between tryptophan metabolites, physical performance, and frailty in older persons","volume":"15","author":"Chow","year":"2022","journal-title":"Int. J. Tryptophan. Res."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"57606","DOI":"10.18632\/oncotarget.11586","article-title":"Expression and regulation of immune-modulatory enzyme indoleamine 2,3-dioxygenase (IDO) by human airway epithelial cells and its effect on T cell activation","volume":"7","author":"Aldajani","year":"2016","journal-title":"Oncotarget"},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13287-020-02118-3","article-title":"Inflammatory cytokines-stimulated human muscle stem cells ameliorate ulcerative colitis via the IDO-TSG6 axis","volume":"12","author":"Zhang","year":"2021","journal-title":"Stem. Cell Res. Ther."},{"key":"ref_232","doi-asserted-by":"crossref","unstructured":"Meireson, A., Devos, M., and Brochez, L. (2020). IDO expression in cancer: Different compartment, different functionality?. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.531491"},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1017\/S1461145713001673","article-title":"Inhibition of stress-induced hepatic tryptophan 2,3-dioxygenase exhibits antidepressant activity in an animal model of depressive behaviour","volume":"17","author":"Gibney","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12974-016-0563-1","article-title":"Interactions between inflammatory mediators and corticosteroids regulate transcription of genes within the kynurenine pathway in the mouse hippocampus","volume":"13","author":"Brooks","year":"2016","journal-title":"J. Neuroinflamm."},{"key":"ref_235","doi-asserted-by":"crossref","unstructured":"Fang, C., Hayashi, S., Du, X., Cai, X., Deng, B., Zheng, H., Ishido, S., Tsutsui, H., and Sheng, J. (2021). Caffeine protects against stress-induced murine depression through activation of PPAR\u03b3C1\u03b1-mediated restoration of the kynurenine pathway in the skeletal muscle. Sci. Rep., 11.","DOI":"10.1038\/s41598-021-86659-4"},{"key":"ref_236","doi-asserted-by":"crossref","unstructured":"Khadka, S., Druffner, S.R., Duncan, B.C., and Busada, J.T. (2023). Glucocorticoid regulation of cancer development and progression. Front. Endocrinol., 14.","DOI":"10.3389\/fendo.2023.1161768"},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"6795","DOI":"10.1158\/0008-5472.CAN-17-2285","article-title":"Discovery of IDO1 inhibitors: From bench to bedside","volume":"77","author":"Prendergast","year":"2017","journal-title":"Cancer Res."},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1038\/s12276-023-01028-7","article-title":"Immune regulation through tryptophan metabolism","volume":"55","author":"Seo","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"ref_239","doi-asserted-by":"crossref","unstructured":"Passarelli, A., Pisano, C., Cecere, S.C., Di Napoli, M., Rossetti, S., Tambaro, R., Ventriglia, J., Gherardi, F., Iannacone, E., and Venanzio, S.S. (2022). Targeting immunometabolism mediated by the IDO1 Pathway: A new mechanism of immune resistance in endometrial cancer. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.953115"},{"key":"ref_240","doi-asserted-by":"crossref","unstructured":"Muller, A.J., Mondal, A., Dey, S., and Prendergast, G.C. (2023). IDO1 and inflammatory neovascularization: Bringing new blood to tumor-promoting inflammation. Front. Oncol., 13.","DOI":"10.3389\/fonc.2023.1165298"},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"1777625","DOI":"10.1080\/2162402X.2020.1777625","article-title":"Trial watch: IDO inhibitors in cancer therapy","volume":"9","author":"Galluzzi","year":"2020","journal-title":"Oncoimmunology"},{"key":"ref_242","doi-asserted-by":"crossref","unstructured":"Tan, Y., Liu, M., Li, M., Chen, Y., and Ren, M. (2022). Indoleamine 2, 3-dioxygenase 1 inhibitory compounds from natural sources. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.1046818"},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2147\/NDS.S166195","article-title":"Whey protein supplementation and muscle mass: Current perspectives","volume":"11","author":"Naclerio","year":"2019","journal-title":"Nutr. Diet. Suppl."},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jamda.2017.05.026","article-title":"Minerals and Sarcopenia; The Role of Calcium, Iron, Magnesium, Phosphorus, Potassium, Selenium, Sodium, and Zinc on Muscle Mass, Muscle Strength, and Physical Performance in Older Adults: A Systematic Review","volume":"19","author":"Abdelrazek","year":"2018","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1002\/jcsm.13057","article-title":"The beneficial therapeutic effects of plant-derived natural products for the treatment of sarcopenia","volume":"13","author":"Bagherniya","year":"2022","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.metabol.2017.11.017","article-title":"Circadian regulation of glucose, lipid, and energy metabolism in humans","volume":"84","author":"Poggiogalle","year":"2018","journal-title":"Metabolism"},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.cmet.2021.03.020","article-title":"The many actions of insulin in skeletal muscle, the paramount tissue determining glycemia","volume":"33","author":"Sylow","year":"2021","journal-title":"Cell Metab."},{"key":"ref_248","first-page":"1022-16","article-title":"Overexpression of SIRT6 suppresses TNF\u03b1-induced muscle cell atrophy via NF\u03baB Inhibition","volume":"31","author":"Yeo","year":"2018","journal-title":"FASEB J."},{"key":"ref_249","doi-asserted-by":"crossref","unstructured":"Zhiyin, L., Jinliang, C., Qiunan, C., Yunfei, Y., and Qian, X. (2021). Fucoxanthin rescues dexamethasone induced C2C12 myotubes atrophy. Biomed. Pharmacother., 139.","DOI":"10.1016\/j.biopha.2021.111590"},{"key":"ref_250","doi-asserted-by":"crossref","unstructured":"Tao, W., Ouyang, Z., Liao, Z., Li, L., Zhang, Y., Gao, J., Ma, L., and Yu, S. (2023). Ursolic acid alleviates cancer cachexia and prevents muscle wasting via activating SIRT1. Cancers, 15.","DOI":"10.3390\/cancers15082378"},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"5441","DOI":"10.1093\/nar\/gky234","article-title":"LSD1 mediates metabolic reprogramming by glucocorticoids during myogenic differentiation","volume":"46","author":"Anan","year":"2018","journal-title":"Nucleic. Acids. Res."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/15\/7616\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:24:38Z","timestamp":1760034278000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/15\/7616"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,6]]},"references-count":251,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["ijms26157616"],"URL":"https:\/\/doi.org\/10.3390\/ijms26157616","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,6]]}}}